Abbott announced US availability of Lingo, the company's first continuous glucose monitoring system available without a prescription. The Lingo system includes a biosensor and a mobile app designed for consumers who want to improve their overall health and wellness. Lingo is based on Abbott's world-leading FreeStyle Libre continuous glucose monitoring technology, now used by more than 6 million people with diabetes globally.

Lingo is available for consumers 18 years and older not on insulin. Lingo tracks glucose in real-time and provides personal insights and coaching to help people build healthy habits, retrain their metabolism and improve their overall well-being. The Lingo system combines a biosensor that is worn on the back of the arm for up to 14 days and continuously streams glucose data to the Lingo app on a smart phone – translating the body's reaction to food, exercise and life's daily stressors.   

Key features of the Lingo experience include - A graph of glucose reactions updates in real time based on continuous readings from the Lingo biosensor, the Lingo Count displaying the body's glucose spikes translated into one, easy-to-understand metric, food and activity logging, and personal Insights showing tailored recommendations based on foods logged, time of day and accrued Lingo Count. Lingo is also available in the UK.